This research highlights that inhibiting the SDF-1-CXCR4 axis, a key signaling pathway that regulates the accumulation and function of immune cells in osteosarcoma, can suppress tumor growth and enhance immune responses. Here, CXCR4 is linked to osteosarcoma.